113 related articles for article (PubMed ID: 1913456)
1. Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in advanced gastric cancers.
Kimura H; Yonemura Y; Epstein AL
Cancer; 1991 Nov; 68(10):2175-80. PubMed ID: 1913456
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.
Fu KK; Hammond E; Pajak TF; Clery M; Doggett RL; Byhardt RW; McDonald S; Cooper JS
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):661-71. PubMed ID: 7913703
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in patients with renal cell carcinoma.
Yokogi H
Cancer; 1996 Aug; 78(4):819-26. PubMed ID: 8756377
[TBL] [Abstract][Full Text] [Related]
4. Proliferative activity in gastric cancer determined with cell cycle-related monoclonal antibodies Ki-67 and p105: analysis by flow cytometry.
Kimura H; Yonemura Y; Miyazaki I
J Surg Oncol; 1992 Nov; 51(3):174-8. PubMed ID: 1359195
[TBL] [Abstract][Full Text] [Related]
5. The expression of proliferative-associated nuclear antigen p105 in gastric carcinoma.
Yonemura Y; Ohoyama S; Kimura H; Kamata T; Matsumoto H; Yamaguchi A; Kosaka T; Miwa K; Miyazaki I
Cancer; 1991 May; 67(10):2523-8. PubMed ID: 2015552
[TBL] [Abstract][Full Text] [Related]
6. Multiparameter flow cytometric analysis of neoplasms of the central nervous system: correlation of nuclear antigen p105 and DNA content with clinical behavior.
Appley AJ; Fitzgibbons PL; Chandrasoma PT; Hinton DR; Apuzzo ML
Neurosurgery; 1990 Jul; 27(1):83-96. PubMed ID: 2377285
[TBL] [Abstract][Full Text] [Related]
7. [Flow cytometric quantitation of the proliferation associated nuclear antigen p105 and DNA content of advanced gastric cancers as a prognostic factor: preliminary report].
Kimura H; Yonemura Y; Ohyama S; Kamata T; Kosaka T; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1990 Jun; 91(6):786. PubMed ID: 1975943
[No Abstract] [Full Text] [Related]
8. Flow cytometric analysis of pituitary tumors. Correlation of nuclear antigen p105 and DNA content with clinical behavior.
Fitzgibbons PL; Appley AJ; Turner RR; Bishop PC; Parker JW; Breeze RE; Weiss MH; Apuzzo ML
Cancer; 1988 Oct; 62(8):1556-60. PubMed ID: 3048631
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric measurements of proliferation-associated nuclear antigen p105 and DNA content in non-Hodgkin's lymphomas.
Turner RR; Layfield LJ; Bishop PC; Epstein AL; Parker JW
Arch Pathol Lab Med; 1989 Aug; 113(8):907-11. PubMed ID: 2569301
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric DNA and nuclear antigen content in astrocytic neoplasms.
Fitzgibbons PL; Turner RR; Appley AJ; Bishop PC; Nichols PW; Epstein AL; Apuzzo ML; Chandrasoma PT
Am J Clin Pathol; 1988 May; 89(5):640-4. PubMed ID: 2895977
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric analysis of nuclear DNA content in advanced gastric cancer and its relationship with prognosis.
Kimura H; Yonemura Y
Cancer; 1991 May; 67(10):2588-93. PubMed ID: 2015558
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of p105 expression and malignancy in gastric cancers].
Yonemura Y; Oyama S; Kimura H; Kamata T; Yamaguchi A; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1991 Feb; 92(2):118-21. PubMed ID: 1674814
[TBL] [Abstract][Full Text] [Related]
13. [Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in gastric cancer: preliminary report].
Kimura H; Yonemura Y; Ohyama S; Kamata T; Kosaka T; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1990 Feb; 91(2):293. PubMed ID: 1970113
[No Abstract] [Full Text] [Related]
14. [Quantitative estimation of malignancy of gastric cancer by DNA ploidy and proliferative activities].
Yonemura Y; Miyazaki I
Rinsho Byori; 1990 Sep; 38(9):1053-8. PubMed ID: 2232266
[TBL] [Abstract][Full Text] [Related]
15. P105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: a clinical/laboratory correlative analysis of RTOG-9003.
Hammond E; Berkey BA; Fu KK; Trotti A; Meredith RF; Jones CU; Byhardt R; Horwitz EM; Ang KK
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):683-92. PubMed ID: 14529772
[TBL] [Abstract][Full Text] [Related]
16. Prediction of lymph node metastasis and prognosis from the assay of the expression of proliferating cell nuclear antigen and DNA ploidy in gastric cancer.
Yonemura Y; Fonseca L; Tsugawa K; Ninomiya I; Matsumoto H; Sugiyama K; Ohoyama S; Fushida S; Kimura H; Miyazaki I
Oncology; 1994; 51(3):251-7. PubMed ID: 7910957
[TBL] [Abstract][Full Text] [Related]
17. Independent clinical and flow cytometric prognostic factors for the survival of patients with stage I gastric cancer.
Yonemura Y; Ohoyama S; Kimura H; Matumoto H; Ninomiya I; Kosaka T; Yamaguchi A; Miwa K; Miyazaki I
Surg Today; 1992; 22(5):416-20. PubMed ID: 1421862
[TBL] [Abstract][Full Text] [Related]
18. [Malignancy in gastric carcinoma, with special reference to the DNA ploidy and proliferative activity].
Yonemura Y; Sugiyama K; Kamata T; Fujimura T; Yamaguchi A; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1988 Aug; 89(8):1175-80. PubMed ID: 3054478
[TBL] [Abstract][Full Text] [Related]
19. [Flow cytometric analysis of DNA ploidy pattern in advanced gastric cancer and its relationship with prognosis].
Kimura H; Yonemura Y; Iwasa K; Ohyama S; Kosaka T; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):288-92. PubMed ID: 2051980
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of nuclear DNA heterogeneity in gastric cancer.
Imada T; Yamamoto Y; Fukuzawa K; Rino Y; Suda T; Moriwaki Y; Akiyama H; Doi T; Kito F; Takemura H
Jpn J Clin Oncol; 1997 Aug; 27(4):221-6. PubMed ID: 9379507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
